Fierce Pharma October 4, 2024
Eric Sagonowsky

On the same day as Roche’s Pharma Day in London, the biopharma giant revealed a high-dollar deal with Chinese-American biotech Regor for the latter’s CDK inhibitors. Meanwhile, Legend’s momentum continued with a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article